Oregon Clinical and Translational Research Institute

俄勒冈临床和转化研究所

• 批准号: 10198068
• 负责人: David H Ellison
• 金额: $ 630.8万
• 依托单位: OREGON HEALTH & SCIENCE UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2017
• 资助国家: 美国
• 起止时间: 2017-09-02 至 2022-08-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10198068
• 关键词: Address; Attitude; Award; Biomedical Research; Businesses; Clinical; Clinical Research; Clinical Trials; Clinical Trials Design; Collaborations; Communities; Competence; Development; Disease; Electronic Health Record; Ensure; Environment; Fostering; Funding Opportunities; Future; Goals; Health Sciences; Healthcare; Individual; Informatics; Institute of Medicine (U.S.); Institutes; Institution; Leadership; Mentors; Modeling; Oregon; Outcome Measure; Patient Recruitments; Patients; Phase; Population; Positioning Attribute; Process; Reporting; Research; Research Design; Research Institute; Research Personnel; Research Project Grants; Science; Services; Special Population; Speed; Statistical Methods; Structure; Testing; Training; Translational Research; Universities; Vision; Voice; Work; Workforce Development; bench to bedside; career; career development; clinical care; community based participatory research; community building; community engaged research; community engagement; experience; improved; informatics tool; innovation; member; model development; next generation; novel therapeutics; programs; recruit; response; skills; success; translational scientist

The Oregon Clinical and Translational Research Institute (OCTRI) has been accelerating research at Oregon Health & Science University since 2006. Its many highly functional programs assist investigators and trainees by providing diverse services. Here, we propose that OCTRI will transition to retain our strengths, but also become a key hub in the national network, by focusing on five crosscutting aims. These align closely with the goals of the Funding Opportunity Announcement, and the goals outlined by NCATS for the CTSA program in an ideal state. OCTRI's overall aims are to: Overall Aim 1: Catalyze Clinical and Translational Research. Overall Aim 2: Enhance Partnerships with Communities. Overall Aim 3: Foster and Support Scientific Collaboration. Overall Aim 4: Expand the Translational Workforce for the 21st Century. Overall Aim 5: Cultivate Innovation in Research. We have organized a highly functional leadership structure to enable us to meet these goals, and will seek the guidance of several advisory groups. We will catalyze research by developing and supporting new informatics approaches that both integrate the clinical care enterprise with the research enterprise and facilitate the recruitment of patients into clinical trials, locally and across the CTSA network. We will engage diverse stakeholders in the translational research process, by partnering with OHSU investigators, community coalitions, and business enterprises. We will foster team science through local awards to trainees and to emerging investigators. We will partner with regional institutions to foster community-engaged research, to enhance the diversity of trainees, and to provide opportunities in biomedical research not available at other institutions. We will train clinical and translational scientists and research staff for the next generation, by focusing on the skills and attitudes necessary for research in the future. At all steps, we will measure outcomes and, when necessary, “turn the curve.”

俄勒冈州临床和翻译研究所(OCTRI)一直在加速俄勒冈州的研究 2006年起就读于健康与科学大学。它的许多功能强大的程序帮助调查人员和实习生 通过提供多样化的服务。在此，我们建议OCTRI将过渡到保留我们的优势，但也 通过专注于五个贯穿各领域的目标，成为国家网络中的关键枢纽。这些都与 融资机会公告的目标，以及NCATS在#年为CTSA计划概述的目标 理想的状态。OCTRI的总体目标是： 总体目标1：促进临床和转化性研究。 总体目标2：加强与社区的伙伴关系。 总体目标3：促进和支持科学协作。 总体目标4：扩大面向21世纪的翻译队伍。 总体目标5：在研究中培养创新能力。 我们组织了一个功能强大的领导结构，使我们能够实现这些目标，并将寻求 几个咨询小组的指导。我们将通过开发和支持新的信息学来促进研究 将临床护理企业与研究企业相结合，并促进 在当地和整个CTSA网络中招募患者参加临床试验。我们将开展多种形式的合作 通过与OHSU调查人员、社区合作，在翻译研究过程中的利益相关者 联盟和商业企业。我们将通过向受训人员和 新兴的调查人员。我们将与地区机构合作，促进社区参与的研究，以 增强受训人员的多样性，并提供其他机构没有的生物医学研究机会 机构。我们将为下一代培训临床和翻译科学家和研究人员，通过 专注于未来研究所需的技能和态度。在所有步骤中，我们都将衡量结果 而且，在必要的时候，“转弯”。